- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 81.92M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.26M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.31M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.33M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.46M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.91M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.02M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.92M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.16M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $3.46M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 81.55M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $8.01K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $126.78K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $295.84K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$278.11K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$281.52K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $21.93K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $497.82K |
| Revenue | Q1 2025 · Mar 31, 2024 | $519.75K |